Velarion Records
Free. Unsubscribe any time.

GALECTIN THERAPEUTICS INC (GALT)

GALECTIN THERAPEUTICS INC filed 24 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 61 transactions and 846,420 shares. 24 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in GALECTIN THERAPEUTICS INC 61

Adoption dates in GALECTIN THERAPEUTICS INC 4

Results prints in GALECTIN THERAPEUTICS INC 7

Trades before a print in GALECTIN THERAPEUTICS INC 8

Interval to GALECTIN THERAPEUTICS INC’s next reported results date

How the interval and sources are counted →

Adoption dates GALECTIN THERAPEUTICS INC states

Filing text: “10b5-1 plan adopted by the reporting person on April 17, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window (2025-10-22), which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.